Effects of Virtual Reality and Tablet Distraction During IV Cannulation in Children
28 de julio de 2026 actualizado por: Deniz Akkaya Balcı, Aydin Adnan Menderes University
The Effect of Watching an Entertaining Video With Virtual Reality Glasses and a Tablet on Pain, Anxiety, and Fear During Intravenous Cannulation in Children in the Emergency Department: A Randomized Controlled Trial
This randomized controlled trial was conducted to evaluate the effects of virtual reality and tablet-based audiovisual distraction on pain, anxiety, and fear in children undergoing intravenous cannulation in a pediatric emergency department.
Children aged 7 to 12 years were randomly assigned to three groups: virtual reality, tablet, and control.
During intravenous cannulation, children in the virtual reality group watched an entertaining video using a virtual reality headset, while children in the tablet group watched the same video on a tablet.
Children in the control group received routine care without an audiovisual distraction intervention.
Pain, anxiety, and fear were assessed using age-appropriate validated scales.
The study compared the effects of the two distraction methods with routine care and with each other.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
The study was designed as a randomized controlled trial involving children aged 7 to 12 years who required intravenous cannulation in a pediatric emergency department. Eligible participants were randomly assigned in a 1:1:1 ratio to a virtual reality group, a tablet group, or a control group.
Children assigned to the virtual reality group watched an entertaining audiovisual video using a virtual reality headset during intravenous cannulation. Children assigned to the tablet group watched the same video on a tablet during the procedure. Children in the control group underwent intravenous cannulation according to the routine clinical practice of the emergency department without an audiovisual distraction intervention.
Anxiety and fear were assessed immediately before intravenous cannulation and again five minutes after the procedure. Pain was assessed immediately after intravenous cannulation. The primary purpose of the study was to determine whether virtual reality and tablet-based distraction reduced procedure-related pain, anxiety, and fear and to compare the effectiveness of these interventions.
Tipo de estudio
Intervencionista
Inscripción (Actual)
132
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Kütahya
-
Kütahya, Kütahya, Turquía (Türkiye), 4300
- Kütahya Evliya Çelebi Training and Research Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- It was that the child belonged to the 7-12 age group and was fully conscious.
Exclusion Criteria:
- Children with hearing, cognitive, or visual impairments; children unaccompanied by a parent; children with whom communication cannot be established; and children with critical health issues and/or conditions requiring immediate intervention.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Virtual Reality Group
Children watched an age-appropriate entertaining video using a virtual reality headset during intravenous cannulation.
|
Children in the virtual reality group received virtual reality-based distraction during intravenous cannulation.
A virtual reality headset was used to divert the child's attention from the procedure.
|
|
Experimental: tablet Group
Children watched the same age-appropriate entertaining video on a tablet during intravenous cannulation.
|
Children in the tablet group watched an age-appropriate cartoon on a tablet during intravenous cannulation to divert their attention from the procedure.
|
|
Sin intervención: control group
Children underwent intravenous cannulation according to routine clinical practice without any audiovisual distraction intervention.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain During Intravenous Cannulation
Periodo de tiempo: Immediately after intravenous cannulation
|
Pain intensity was assessed using the Wong-Baker FACES Pain Rating Scale.
The scale consists of six facial expressions representing increasing levels of pain.
Scores range from 0 to 10, with higher scores indicating greater pain intensity.
Pain was assessed immediately after intravenous cannulation.
|
Immediately after intravenous cannulation
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Anxiety Before and After Intravenous Cannulation
Periodo de tiempo: Immediately before and immediately after intravenous cannulation
|
Anxety was assesed using the scale .Higher scores indicate greater anxiety.
|
Immediately before and immediately after intravenous cannulation
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de abril de 2022
Finalización primaria (Actual)
1 de agosto de 2022
Finalización del estudio (Actual)
1 de agosto de 2022
Fechas de registro del estudio
Enviado por primera vez
28 de julio de 2026
Primero enviado que cumplió con los criterios de control de calidad
28 de julio de 2026
Publicado por primera vez (Actual)
31 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
31 de julio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
28 de julio de 2026
Última verificación
1 de julio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2021/284
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .